2m 2m 2m 2m 2m 2m 2m
CORMEDIX (CRMD)
NASDAQ
$8.28+$0.11 (+1.29%)
Price as of Jun 03, 2026 6:08 PM EDT- $662.1MMarket Cap
- -35.21%1-Year Change
- BiotechnologyIndustry
CORMEDIX (CRMD)
$8.28+$0.11 (+1.29%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 304.3M +600.09% | 43.5M +448,853.53% | 9,683 -85.20% | 65,408 -65.74% | |
Cost of Revenue | 22.1M +592.33% | 3.2M N/A | N/A N/A | 3,734 -97.49% | |
Gross Profit | 275.7M +584.55% | 40.3M +415,903.68% | 9,683 -84.30% | 61,674 +46.85% | |
Sales and Marketing Expense | 38.1M +32.42% | 28.7M -19.74% | 35.8M +78.96% | 20.0M +22.39% | |
Research and Development Expense | -19.3M +390.40% | -3.9M -70.03% | -13.2M +23.18% | -10.7M -18.68% | |
Depreciation and Amortization Expense | 13.9M +8,801.21% | 155,844 +120.26% | 70,755 -16.38% | 84,618 +36.72% | |
Total Operating Expenses | 125.6M +100.53% | 62.6M +27.94% | 49.0M +59.55% | 30.7M +4.09% | |
Operating Profit | 150.1M +771.58% | -22.4M -54.34% | -49.0M +59.87% | -30.6M +4.03% | |
Interest Income | 3.8M +49.14% | 2.6M -3.84% | 2.7M +722.61% | 326,016 +2,163.53% | |
Interest Expense | N/A N/A | N/A N/A | -34,296 +29.35% | -26,515 +66.31% | |
Interest Income and Expense and Net | 3.8M +49.14% | 2.6M -2.60% | 2.6M +783.99% | 299,501 +19,548.12% | |
Total Nonoperating Income and Expense | -125,000 -104.12% | 3.0M +15.77% | 2.6M +677.84% | 336,646 +1,574.77% | |
Income before Taxes | 150.0M +876.29% | -19.3M -60.53% | -49.0M +61.64% | -30.3M +2.81% | |
Income Taxes | -13.0M +834.85% | -1.4M -322.81% | 626,000 +206.90% | -585,617 -53.16% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 163.1M +1,009.40% | -17.9M -61.31% | -46.3M +56.02% | -29.7M +5.29% | |
Net Income from Continuing Operations Applicable to Common | 150.0M +876.29% | -19.3M -58.30% | -46.3M +53.00% | -30.3M +2.81% | |
Basic EPS and Net Income | 2.25 +850.00% | -0.30 -67.03% | -0.91 +22.97% | -0.74 -1.33% | |
Diluted EPS and Net Income | 2.04 +780.00% | -0.30 -67.03% | -0.91 +22.97% | -0.74 -1.33% | |
Basic Weighted Average Shares | 72,034 -99.88% | 58.9M +15.65% | 50.9M +26.39% | 40.3M +6.92% | |
Diluted Weighted Average Shares | 80,308 -99.86% | 58.9M +15.65% | 50.9M +26.39% | 40.3M +6.92% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 144.8M +256.30% | 40.7M -6.86% | 43.6M +1.15% | 43.1M -19.07% | |
Short-Term Investments | 3.7M -66.53% | 11.0M -65.92% | 32.4M +107.03% | 15.6M +28.77% | |
Cash and Cash Equivalents and Short-Term Investments | 148.5M +187.36% | 51.7M -32.02% | 76.0M +29.32% | 58.8M -10.19% | |
Total Current Assets | 367.1M +220.36% | 114.6M +44.21% | 79.5M +33.42% | 59.6M -10.41% | |
Accumulated Depreciation | N/A N/A | 674,000 +29.48% | 520,542 +15.73% | 449,787 +23.17% | |
Property and Plant and Equipment and Net | 6.0M +225.98% | 1.8M -2.05% | 1.9M +15.94% | 1.6M +9.14% | |
Total Long-Term Assets | 6.0M +225.98% | 1.8M -2.05% | 1.9M +15.94% | 1.6M +9.14% | |
Total Assets | 826.1M +595.14% | 118.8M +44.83% | 82.1M +32.27% | 62.0M -10.02% | |
Income Taxes Payable | 15.1M N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 174.3M +414.98% | 33.8M +196.83% | 11.4M +80.65% | 6.3M +18.07% | |
Total Long-Term Debt | 144,626 N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 2.3M +545.39% | 349,091 -32.48% | 517,013 -22.56% | 667,632 -16.80% | |
Total Liabilities | 420.8M +1,130.92% | 34.2M +186.88% | 11.9M +70.77% | 7.0M +13.52% | |
Retained Earnings | -176.6M -48.01% | -339.6M +5.57% | -321.7M +16.83% | -275.4M +12.09% | |
Total Stockholders Equity | 405.3M +378.76% | 84.7M +20.69% | 70.1M +27.39% | 55.1M -12.32% | |
Total Shares Outstanding | 79.3M +23.05% | 64.4M +17.24% | 54.9M +28.31% | 42.8M +12.42% | |
Cash Flow | |||||
Cash from Operating Activities | 175.0M +445.84% | -50.6M +31.78% | -38.4M +57.70% | -24.4M +15.13% | |
Capital Expenditures | 2.3M +1,852.82% | 115,730 -64.64% | 327,300 +49.21% | 219,360 -84.61% | |
Cash from Investing Activities | -308.4M -1,552.75% | 21.2M +224.44% | -17.1M +359.96% | -3.7M -59.39% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 238.5M +806.02% | 26.3M -52.93% | 55.9M +212.42% | 17.9M -57.14% | |
Financials Ratio | |||||
Gross Margin | 92.74% +0.09% | 92.66% N/A | N/A N/A | 94.29% +328.68% | |
Operating Margin | 49.33% +195.93% | -51.43% -99.99% | -505,605.58% +979.89% | -46,819.91% +203.68% | |
Return on Assets | 34.51% +293.34% | -17.85% -72.25% | -64.32% +41.82% | -45.35% -4.95% | |
Return on Equity | 66.56% +387.32% | -23.17% -68.70% | -74.02% +46.86% | -50.40% -4.39% | |
Revenue Growth | 600.09% -99.87% | 448,853.53% +526,948.12% | -85.20% +29.59% | -65.74% +225.66% | |
Current Ratio | 2.11 -37.79% | 3.39 -51.42% | 6.97 -26.15% | 9.44 -24.12% | |
Cash Ratio | 0.83 -30.82% | 1.20 -68.62% | 3.83 -44.01% | 6.84 -31.46% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow